Prakash Steelage Limited Receives Show Cause Notice from SEBI
Prakash Steelage Limited confirmed on April 22, 2026, that it has received a Show Cause Notice from the Securities and Exchange Board of India (SEBI). The notice, dated April 21, 2026, addresses allegations concerning violations of various regulations laid out by the SEBI.The notice was issued under Rule 4(1) of the SEBI (Procedure for Holding Inquiry and Imposing Penalties) Rules, 1995. The core of the matter revolves around alleged violations pertaining to Regulations 4(1)(a), (b), (c), (d), (e), (h), (i), 4(2)(e)(i), 23(9), 33(1)(a), 33(1)(c), and 34(3) of the Listing Obligations and Disclosure Requirements (LODR) Regulations, in addition to Clause B(2) of Schedule V & 48 of the LODR Regulations.
The Chief General Manager and Adjudicating Officer of SEBI issued the Show Cause Notice regarding the matter.
In response to the notice, Prakash Steelage Limited stated that it is currently in the process of preparing its official reply. The company confirmed it will furnish its response within the timelines permitted by SEBI.
PRAKASHSTL Stock Price Movement
Prakash Steelage Limited shares today slipped by 0.21% to settle at ₹4.84. The stock finished the day with a total traded volume of 168,448 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.